Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study-Reference-Cited by-同舟云学术

Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study

Published:2024-07-22 Issue:8 Volume:14 Page:2209-2221
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Torres Tiago^ORCID,Cruz Maria João,Gonçalo Margarida,Filipe Paulo,Duarte Bruno,Alves João,Alvarenga José Miguel,Rosa Gilberto,Flor Duarte,Ramos José,Sousa Diogo,Rosca Aureliu,Magalhães César,Claro Cristina,Rocha Joana,Vilarinho Catarina,Mota Fernando,Mota Alberto,Lopes Maria João Paiva

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13555-024-01235-8.pdf

Reference31 articles.

1. Schuler CF, Billi AC, Maverakis E, Tsoi LC, Gudjonsson JE. Novel insights into atopic dermatitis. J Allergy Clin Immunol [Internet]. 2023;151(5):1145–54. Available from: https://doi.org/10.1016/j.jaci.2022.10.023

2. Sroka-Tomaszewska J, Trzeciak M. Molecular mechanisms of atopic dermatitis pathogenesis. Int J Mol Sci. 2021;22(8).

3. Torres T, Ferreira EO, Gonçalo M, Mendes-bastos P. Update on Atopic Dermatitis A Dermatite Atópica em Revisão. Orden Dos Médicos [Internet]. 2019;32(9):606–13. Available from: https://doi.org/10.20344/amp.11963

4. Neagu N, Dianzani C, Avallone G, Dell’Aquila C, Morariu SH, Zalaudek I, et al. Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review. J Eur Acad Dermatology Venereol. 2022;36(6):820–35.

5. Gooderham MJ, Hong HC ho, Eshtiaghi P, Papp KA. Dupilumab A review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol. 2018;78(3):S28–36. https://doi.org/10.1016/j.jaad.2017.12.022